European Heart Journal Advance Access published online on January 27, 2006
European Heart Journal, doi:10.1093/eurheartj/ehi734
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Cardiology, Hôpital Pontchaillou-CHU, 2, rue Henri Le Guilloux, 35033 Rennes, Cedex 09, France
* To whom correspondence should be addressed. Despite the alleviation of symptoms and longer survival conferred by pharmacological management of chronic congestive heart failure (CHF), this progressive syndrome remains associated with high morbidity and premature death. A new treatment of CHF should ideally alleviate symptoms, improve functional capacity, decrease mortality, and slow or reverse its progression without adding risks for the patient that outweighs the benefits. Growing evidence indicates that devices implanted to resynchronize ventricular contraction are a beneficial adjunct in the treatment of CHF. This review discusses the remodelling process, and its clinical and prognostic significance. We also discuss the impact of CRT, on remodelling and disease progression with a particular focus on patients with asymptomatic or mild heart failure (NYHA Class I-II).
Received July 2, 2005
Revised December 17, 2005
Accepted December 22, 2005
Review
Effects of cardiac resynchronization therapy on disease progression in chronic heart failure
Erwan Donal 1,
Christophe Leclercq 1,
Cecilia Linde 2,
and
Jean-Claude Daubert 1 *
2 Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden
Jean-Claude Daubert, E-mail: jean-claude.daubert{at}chu-rennes.fr
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Daubert, M. R. Gold, W. T. Abraham, S. Ghio, C. Hassager, G. Goode, T. Szili-Torok, C. Linde, and on behalf of the REVERSE Study Group Prevention of Disease Progression by Cardiac Resynchronization Therapy in Patients With Asymptomatic or Mildly Symptomatic Left Ventricular Dysfunction: Insights From the European Cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) Trial J. Am. Coll. Cardiol., November 10, 2009; 54(20): 1837 - 1846. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Leclercq, F. Gadler, W. Kranig, S. Ellery, D. Gras, A. Lazarus, J. Clementy, E. Boulogne, J.-C. Daubert, and for the TRIP-HF (Triple Resynchronization In Paced A Randomized Comparison of Triple-Site Versus Dual-Site Ventricular Stimulation in Patients With Congestive Heart Failure J. Am. Coll. Cardiol., April 15, 2008; 51(15): 1455 - 1462. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Garcia-Bolao, B. Lopez, A. Macias, J. J. Gavira, P. Azcarate, and J. Diez Impact of collagen type I turnover on the long-term response to cardiac resynchronization therapy Eur. Heart J., April 1, 2008; 29(7): 898 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Kimmel, N. D. Skadsberg, C. L. Byrd, D. J. Wright, T. G. Laske, and P. A. Iaizzo Single-site ventricular and biventricular pacing: investigation of latest depolarization strategy Europace, December 1, 2007; 9(12): 1163 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Hohnloser and E. N. Prystowsky CRT-D use in heart failure: too little or too much? Eur. Heart J. Suppl., September 1, 2007; 9(suppl_G): G9 - G16. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schmidt, J. Frielingsdorf, M. Debrunner, R. Tavakoli, M. Genoni, E. Straumann, O. Bertel, and B. Naegeli Acute biventricular pacing after cardiac surgery has no influence on regional and global left ventricular systolic function Europace, June 1, 2007; 9(6): 432 - 436. [Abstract] [Full Text] [PDF] |
||||



